SUBSCRIBE
SUBSCRIBE

Oregon

Job Trends
BioSpace Showcases Life Sciences Hubs in 2025 Hotbed Maps
BioSpace has revealed its 2025 Hotbed Maps, showcasing nine regional hot spots for life sciences activity.
January 21, 2025
 · 
1 min read
 · 
Chantal Dresner
PRESS RELEASES
Press Releases
Sparrow Pharmaceuticals Collaborates with the University of Oxford and the University of Sheffield on DC-MACS, a Phase 2 Clinical Study of Clofutriben
December 11, 2024
 · 
4 min read
Press Releases
Sparrow Pharmaceuticals to Present Two Abstracts at ACR Convergence 2024 and Expand Phase 2 Clinical Trial of Clofutriben with Prednisolone for Polymyalgia Rheumatica to Fifth Cohort
November 14, 2024
 · 
2 min read
Press Releases
Sparrow Pharmaceuticals Announces Completion of Phase 2 Trial and FDA Orphan Drug Designation of Clofutriben for Endogenous Cushing’s Syndrome
October 28, 2024
 · 
3 min read
Press Releases
Thermo Fisher Scientific Expands Oral Solid Dose Development and Manufacturing Capabilities Across North America
September 27, 2024
 · 
3 min read
Press Releases
Sparrow Pharmaceuticals Presented New Data on Clofutriben and Prednisolone for Polymyalgia Rheumatica Treatment at DGRh Kongress 2024
September 19, 2024
 · 
2 min read
Press Releases
Serán Bioscience Announces $200 Million Strategic Growth Transaction and Plans for New Commercial Facility
September 17, 2024
 · 
5 min read
News
Compassion Center and SIDHE Research Institute Take the Lead in Ethical Hallucinogen Research to Revolutionize Mental Health Treatment
September 11, 2024
 · 
9 min read
News
Quantek Systems and Varian, a Siemens Healthineers Company, Announce Strategic Collaboration to Enhance Clinical Interoperability
July 16, 2024
 · 
2 min read
Drug Development
Sparrow Pharmaceuticals Presents Data from Ongoing Phase 2 Trial of Clofutriben (SPI-62) and Prednisolone as a Treatment for Polymyalgia Rheumatica at EULAR 2024
June 15, 2024
 · 
2 min read
Drug Development
Sparrow Pharmaceuticals to Present on HSD-1 Inhibitor Clofutriben (SPI-62) for Polymyalgia Rheumatica at the European Congress of Rheumatology 2024
June 6, 2024
 · 
1 min read
Drug Development
Ankyra Therapeutics Announces Trial in Progress Poster Presentation at 2024 ASCO Meeting and Approval of ANK-101 Phase 1 Protocol Amendment
June 1, 2024
 · 
4 min read
BioForest
Sparrow Pharmaceuticals’ David Katz, PhD, to Receive Outstanding Innovation Award at the 2024 Annual Endocrine Society Conference
May 30, 2024
 · 
2 min read
BioForest
Molecular You Announces Breakthrough in Early Detection of Pancreatic Cancer
April 22, 2024
 · 
3 min read
BioForest
Bruker Advances CCS-Enabled 4D-Proteomics timsTOF Solutions for Immunopeptidomes and Glycoproteomics at US HUPO
March 11, 2024
 · 
6 min read
Business
EndoSound™ Inc., Appoints Medical Device Commercial Leader Scott Aldrich Jr as Chief Executive Officer
February 29, 2024
 · 
2 min read
BioForest
Phylos® and People Science® Announce Results of IRB-Backed Controlled Research Study on the Energizing Effects of THCV
February 27, 2024
 · 
4 min read
BioForest
Study of First Affordable and Rapid Test for Beta Thalassemia Performs at 99% Accuracy in Diagnosing the Blood Disorder
February 5, 2024
 · 
1 min read
BioForest
EndoSound® Receives 510(k) Clearance for Breakthrough EVS® Innovation, a novel Endoscopic Ultrasound (EUS) technology
January 2, 2024
 · 
2 min read
Drug Development
Cascade Announces Poster Presentation at Society for Immunotherapy of Cancer (SITC) Annual Meeting
October 24, 2023
 · 
2 min read
Drug Development
Sparrow Pharmaceuticals Doses First Patient in Phase 2 ACSpire Study of SPI-62 for Autonomous Cortisol Secretion
October 24, 2023
 · 
3 min read
Load More